On the Use of Markov Models in Pharmacoeconomics: Pros and Cons and Implications for Policy Makers

Carta A
First
Methodology
;Conversano C
Last
Conceptualization
2020-01-01
2020
2020
Inglese
FRONTIERS IN PUBLIC HEALTH
8
569500
1
14
14
WOS:000588710400001
2-s2.0-85095996833
https://www.frontiersin.org/articles/10.3389/fpubh.2020.569500/full
Esperti non anonimi
internazionale
scientifica
pharmacoeconomics, cost-utility analysis, Markov models, Dengue fever, incremental cost effectiveness ratio, willingness to pay
no
Carta, A; Conversano, C
1.1 Articolo in rivista
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
2
none
Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie